Normalization of ovarian reserve surrogates in a women diagnosed with psoriasis treated with TNF-alpha antagonist. A case report

Maturitas ◽  
2019 ◽  
Vol 128 ◽  
pp. 96
Author(s):  
Adam Czyżyk ◽  
Przemysław Ciepiela ◽  
Rafał Kurzawa
Keyword(s):  
Case Report ◽  
Ovarian Reserve ◽  
Tnf Alpha ◽  
Alpha Antagonist

P.1.c.028 Systemically and spinally administered etanercept, a TNF-alpha antagonist, blocks allodynia in diabetic mice

2009 ◽  
Vol 19 ◽  
pp. S267-S268
Author(s):  
A. Dogrul ◽  
H. Gul ◽  
O. Yesilyurt ◽  
U.H. Ulas ◽  
O. Yildiz
Keyword(s):  
Tnf Alpha ◽  
Diabetic Mice ◽  
Alpha Antagonist

TNF-alpha inhibitors in Systemic Lupus Erythematosus. A case report and a systematic literature review

2013 ◽  
Vol 25 (4) ◽  
pp. 642-645 ◽  
Author(s):  
Marta Mosca ◽  
Chiara Tani ◽  
Maria Elena Filice ◽  
Linda Carli ◽  
Andrea Delle Sedie ◽  
...  
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Case Report ◽  
Literature Review ◽  
Systematic Literature Review ◽  
Lupus Erythematosus ◽  
Tnf Alpha ◽  
Systemic Lupus

scholarly journals Pregnancy following Transvaginal Ultrasound-Guided Aspiration and Sclerotherapy of Endometrioma

2011 ◽  
Vol 3 (3) ◽  
pp. 153-154
Author(s):  
Mosammat Rashida Begum ◽  
Hosne Ara Baby
Keyword(s):  
Case Report ◽  
Ovarian Reserve ◽  
Surgical Procedure ◽  
Transvaginal Ultrasound ◽  
Ultrasound Guided

ABSTRACT Many researchers have tried for aspiration of endometrioma followed by alcohol or tetracycline sclerotherapy in order to avoid delicate surgical procedure as well as to keep a functioning ovarian reserve. It has traditionally being used for recurrent cases of endometriomas. But this case report illustrates the importance of applying this procedure in unavoidable and exceptional circumstances.

Using TNF-alpha antagonist Adalimumab for treatment for multisystem sarcoidosis: a case study

2011 ◽  
Vol 32 (8) ◽  
pp. 2367-2370 ◽  
Author(s):  
Tobias Lahmer ◽  
Andreas Knopf ◽  
Ines Lanzl ◽  
Uwe Heemann ◽  
Klaus Thuermel
Keyword(s):  
Tnf Alpha ◽  
Alpha Antagonist

TNF alpha antagonist therapy and safety monitoring

2011 ◽  
Vol 78 ◽  
pp. 15-185 ◽  
Author(s):  
Thao Pham ◽  
Hervé Bachelez ◽  
Jean-Marie Berthelot ◽  
Jacques Blacher ◽  
Yoram Bouhnik ◽  
...  
Keyword(s):  
Safety Monitoring ◽  
Tnf Alpha ◽  
Antagonist Therapy ◽  
Alpha Antagonist

Low-dose methotrexate - a therapeutical kick in TNF-alpha antagonist treatment for recalcitrant psoriasis vulgaris

2013 ◽  
Vol 27 (1) ◽  
pp. 55-59 ◽  
Author(s):  
Dagmar Wilsmann-Theis ◽  
Kristina Fronhoffs ◽  
Lin-Kristin Ehler ◽  
Joerg Wenzel ◽  
Thomas Bieber ◽  
...  
Keyword(s):  
Low Dose ◽  
Psoriasis Vulgaris ◽  
Tnf Alpha ◽  
Dose Methotrexate ◽  
Alpha Antagonist

scholarly journals Improvement of atopic dermatitis and alopecia universalis with dupilumab: a case report

2021 ◽  
Author(s):  
Lama Alotaibi ◽  
Abdulrahman Alfawzan ◽  
Raghad Alharthi ◽  
Afaf Al sheikh
Keyword(s):  
Atopic Dermatitis ◽  
Case Report ◽  
Alopecia Areata ◽  
Alopecia Universalis ◽  
Receptor Alpha ◽  
Alpha Antagonist

Dupilumab is an interleukin (IL)-4 receptor alpha antagonist that showed significant improvement of atopic dermatitis (AD). Many reports have shown significant resolution of alopecia areata, alopecia universalis, and alopecia totalis after dupilumab treatment for AD. We present one of the few reported cases that showed improvement of underlying alopecia universalis treated with dupilumab.

Sign in / Sign up

Export Citation Format

Share Document